Launch of new antiviral against COVID-19

 

A new drug developed by the Defense Research and Development Organization (DRDO) in association with Dr. Reddy’s Laboratories Ltd has been launched following approval for emergency use in the treatmen

 

2-deoxy-d-glucose (2-DG) – Launch of new antiviral against COVID-19.

A new drug developed by the Defense Research and Development Organization (DRDO) in association with Dr. Reddy’s Laboratories Ltd has been launched following approval for emergency use in the treatment of Covid-19 patients by the Drug Control General of India (DCGI).

This drug is only available in India and there is no data from any other country regarding its use in COVID-19 patients.

Comments

Popular posts from this blog

What tests are used to manage anemia and what do they mean?

What are Bioblack C Tablets and What Are Their Benefits for Your Health?

What Should You Expect from a Full Body Blood Test and Checkup?